Bendroflumethiazide

国: ニュージーランド

言語: 英語

ソース: Medsafe (Medicines Safety Authority)

有効成分:

Bendroflumethiazide 2.5mg;  ;  

から入手可能:

Ipca Pharma (NZ) Pty Limited

INN（国際名）:

Bendroflumethiazide 2.5 mg

投薬量:

2.5 mg

医薬品形態:

Tablet

構図:

Active: Bendroflumethiazide 2.5mg     Excipient: Lactose Purified talc Starch Stearic acid

パッケージ内のユニット:

Blister pack, PVC/PVDC, 14 tablets

クラス:

Prescription

処方タイプ:

Prescription

製:

Ipca Laboratories Limited

適応症:

Bendrofluazide is indicated in the treatment of oedema associated with conditions such as: congestive heart failure, nephrotic syndrome and cirrhosis of the liver.

製品概要:

Package - Contents - Shelf Life: Blister pack, PVC/PVDC - 14 tablets - 24 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC - 28 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE - 500 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE - 1000 tablets - 24 months from date of manufacture stored at or below 25°C

承認日:

2006-06-28